394 related articles for article (PubMed ID: 21250763)
1. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
Straubhaar B; Krähenbühl S; Schlienger RG
Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
[TBL] [Abstract][Full Text] [Related]
3. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.
Johnell K; Klarin I
Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
5. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
9. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions.
Souty C; Launay T; Steichen O; Conte C; Turbelin C; Sarazin M; Vilcu AM; Rossignol L; Blanchon T; Lapeyre-Mestre M; Hanslik T
Eur J Clin Pharmacol; 2020 Dec; 76(12):1675-1682. PubMed ID: 32632714
[TBL] [Abstract][Full Text] [Related]
10. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
[TBL] [Abstract][Full Text] [Related]
11. Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the Elderly.
Stader F; Courlet P; Kinvig H; Penny MA; Decosterd LA; Battegay M; Siccardi M; Marzolini C
Clin Pharmacol Ther; 2021 Feb; 109(2):471-484. PubMed ID: 32772364
[TBL] [Abstract][Full Text] [Related]
12. [Potential Drug-Drug Interactions among Three or More Drugs: A Retrospective Multi-center Study in Pharmacies in the Kojima Region, Okayama].
Oka N; Kondo M; Matsubara H; Izushi K; Tasaka Y
Yakugaku Zasshi; 2021; 141(7):979-984. PubMed ID: 34193658
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
Courlet P; Livio F; Guidi M; Cavassini M; Battegay M; Stoeckle M; Buclin T; Alves Saldanha S; Csajka C; Marzolini C; Decosterd L;
Open Forum Infect Dis; 2019 Dec; 6(12):ofz531. PubMed ID: 31909082
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].
Su BB; Ma JX; Song W; Yuan J; Dong XY; Wan J
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1983-1987. PubMed ID: 32629601
[No Abstract] [Full Text] [Related]
16. Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study.
Galai E; Scotti L; Gilardetti M; Ucciero A; Ferrante D; Poluzzi E; Genazzani AA; Barone-Adesi F
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742605
[TBL] [Abstract][Full Text] [Related]
17. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database.
Nobili A; Pasina L; Tettamanti M; Lucca U; Riva E; Marzona I; Monesi L; Cucchiani R; Bortolotti A; Fortino I; Merlino L; Walter Locatelli G; Giuliani G
J Clin Pharm Ther; 2009 Aug; 34(4):377-86. PubMed ID: 19583670
[TBL] [Abstract][Full Text] [Related]
18. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
19. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
20. The impact of number of drugs prescribed on the risk of potentially inappropriate medication among outpatient older adults with chronic diseases.
Weng MC; Tsai CF; Sheu KL; Lee YT; Lee HC; Tzeng SL; Ueng KC; Chen CC; Chen SC
QJM; 2013 Nov; 106(11):1009-15. PubMed ID: 23836694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
